Literature DB >> 36045268

The myocardial flow reserve in patients with heart failure with preserved ejection fraction.

Andrew V Mochula1, Kristina V Kopeva2, Alina N Maltseva2, Elena V Grakova2, Marina Gulya2, Andrey V Smorgon2, Anna Gusakova2, Konstantin V Zavadovsky2.   

Abstract

To evaluate the myocardial flow reserve (MFR) and myocardial blood flow (MBF) parameters in patients with heart failure with preserved ejection fraction (HFpEF) and to assess their relationship with the severity of HF and the levels of soluble ST2 (sST2). A total of 59 consecutive patients (median age of 65.0 (58.0; 69.0) years) with non-obstructive coronary artery disease (CAD) and preserved EF were enrolled. Serum levels biomarkers were measured by enzyme immunoassay. MBF and MFR parameters were evaluated by dynamic CZT-SPECT. All patients were divided into two groups: group 1 comprised patients (n = 41) with HFpEF, and group 2 comprised those (n = 18) without HFpEF. In group 1 global MFR (gMFR) values were lower by 27.8% (p = 0.003) than in group 2. The values of gMFR correlated with NT-proBNP (r = - 0.290) and sST2 (r = -0.331) levels. Based on ROC-analysis, gMFR ≤ 2.27 (AUC = 0.746; p < 0.001) were associated with the presence of HFpEF. In patients with HFpEF (n = 41) the values of gMFR were related to NYHA classes (p < 0.001) and the parameters of diastolic dysfunction (p < 0.001). The values of gMFR ≤ 2.27 may be used for the evaluation of microvascular changes in patients with HFpEF and non-obstructive CAD.
© 2022. Springer Japan KK, part of Springer Nature.

Entities:  

Keywords:  Diastolic dysfunction; Heart failure; Microvascular dysfunction; Myocardial blood flow; Myocardial flow reserve; Preserved ejection fraction

Year:  2022        PMID: 36045268     DOI: 10.1007/s00380-022-02161-5

Source DB:  PubMed          Journal:  Heart Vessels        ISSN: 0910-8327            Impact factor:   1.814


  48 in total

1.  Paradox of normal selective coronary arteriograms in patients considered to have unmistakable coronary heart disease.

Authors:  W Likoff; B L Segal; H Kasparian
Journal:  N Engl J Med       Date:  1967-05-11       Impact factor: 91.245

Review 2.  Clinical significance of noninvasive coronary flow reserve assessment in patients with ischemic heart disease.

Authors:  Viviany R Taqueti; Marcelo F Di Carli
Journal:  Curr Opin Cardiol       Date:  2016-11       Impact factor: 2.161

Review 3.  A novel paradigm for heart failure with preserved ejection fraction: comorbidities drive myocardial dysfunction and remodeling through coronary microvascular endothelial inflammation.

Authors:  Walter J Paulus; Carsten Tschöpe
Journal:  J Am Coll Cardiol       Date:  2013-05-15       Impact factor: 24.094

Review 4.  Molecular and cellular basis for diastolic dysfunction.

Authors:  Loek van Heerebeek; Constantijn P M Franssen; Nazha Hamdani; Freek W A Verheugt; G Aernout Somsen; Walter J Paulus
Journal:  Curr Heart Fail Rep       Date:  2012-12

5.  High-Resolution Cardiac Magnetic Resonance Imaging Techniques for the Identification of Coronary Microvascular Dysfunction.

Authors:  Haseeb Rahman; Cian M Scannell; Ozan M Demir; Matthew Ryan; Hannah McConkey; Howard Ellis; Pier Giorgio Masci; Divaka Perera; Amedeo Chiribiri
Journal:  JACC Cardiovasc Imaging       Date:  2020-11-25

Review 6.  Diagnosis of coronary microvascular dysfunction in the clinic.

Authors:  Peter Ong; Basmah Safdar; Andreas Seitz; Astrid Hubert; John F Beltrame; Eva Prescott
Journal:  Cardiovasc Res       Date:  2020-03-01       Impact factor: 10.787

7.  Absolute myocardial blood flows derived by dynamic CZT scan vs invasive fractional flow reserve: Correlation and accuracy.

Authors:  Konstantin V Zavadovsky; Andrew V Mochula; Alla A Boshchenko; Alexander V Vrublevsky; Andrew E Baev; Alexander L Krylov; Marina O Gulya; Evgeny A Nesterov; Riccardo Liga; Alessia Gimelli
Journal:  J Nucl Cardiol       Date:  2019-03-07       Impact factor: 5.952

8.  2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC)Developed with the special contribution of the Heart Failure Association (HFA) of the ESC.

Authors:  Piotr Ponikowski; Adriaan A Voors; Stefan D Anker; Héctor Bueno; John G F Cleland; Andrew J S Coats; Volkmar Falk; José Ramón González-Juanatey; Veli-Pekka Harjola; Ewa A Jankowska; Mariell Jessup; Cecilia Linde; Petros Nihoyannopoulos; John T Parissis; Burkert Pieske; Jillian P Riley; Giuseppe M C Rosano; Luis M Ruilope; Frank Ruschitzka; Frans H Rutten; Peter van der Meer
Journal:  Eur Heart J       Date:  2016-05-20       Impact factor: 29.983

Review 9.  Myocardial perfusion imaging with PET.

Authors:  Roel S Driessen; Pieter G Raijmakers; Wijnand J Stuijfzand; Paul Knaapen
Journal:  Int J Cardiovasc Imaging       Date:  2017-02-10       Impact factor: 2.357

10.  First validation of myocardial flow reserve assessed by dynamic 99mTc-sestamibi CZT-SPECT camera: head to head comparison with 15O-water PET and fractional flow reserve in patients with suspected coronary artery disease. The WATERDAY study.

Authors:  Denis Agostini; Vincent Roule; Catherine Nganoa; Nathaniel Roth; Raphael Baavour; Jean-Jacques Parienti; Farzin Beygui; Alain Manrique
Journal:  Eur J Nucl Med Mol Imaging       Date:  2018-03-01       Impact factor: 9.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.